In recent years, the global health industry has accelerated its high-quality development, and consumer demand for safe, efficient, and cost-effective scientific nutrition products continues to rise. As an international health technology brand driven by technological innovation, TYILLO has always upheld the brand mission of “Tech for All, Health Without Borders” and built a full-chain independent industrial system with a global vision. At present, TYILLO has established fully owned production bases in five core regions: the United States, New Zealand, the United Kingdom, Hong Kong (China), and Japan. It achieves unified and refined control over the entire process — from raw materials, R&D, and production to finished products. Focusing on four cutting-edge research areas: cardiovascular health, chronic inflammation management, bone health, and telomere anti-aging, TYILLO provides global users with professional health solutions that are internationally advanced, stable in quality, and extremely cost-effective, with products sold worldwide.

Unlike the industry’s common practice of entrusted OEM and decentralized production, TYILLO insists that all five global bases are independently built, operated, and controlled by the brand, ensuring absolute quality control from the source. All bases implement unified R&D standards, production specifications, quality control, and finished product testing, forming a complete closed loop of “one global system, consistent quality across the board”.

- The U.S. base serves as the global R&D and technology hub, focusing on core technological breakthroughs and formula innovation.

- The New Zealand base leverages its pure ecosystem to achieve independent extraction of high-quality natural raw materials.

- The UK base upholds pharmaceutical-grade rigor to ensure product safety and stability.

- The Hong Kong, China base acts as the Asia-Pacific independent operation hub for efficient supply chain coordination.

- The Japanese base enhances product absorption and experience through refined independent processes. All five bases conduct independent production and quality control.

While maintaining world-class quality, TYILLO optimizes costs through large-scale operations, making high-end health technology truly accessible to the public. Technological innovation is at the core of TYILLO’s competitiveness. Based on global frontiers in life sciences, the brand has deeply cultivated four core fields:

- Cardiovascular health: focusing on vascular care and circulatory regulation

- Chronic inflammation management: targeting physical homeostasis and immune balance

- Bone health: covering scientific bone and joint care for all age groups

- Telomere anti-aging: exploring fundamental anti-aging pathways through cutting-edge cell science

This has formed a professional product matrix covering the entire life cycle. Relying on a fully independent industrial chain and strict quality control system, TYILLO’s global production bases comply with internationally authoritative production standards. Its products have obtained multiple international certifications, and each batch undergoes rigorous multi-stage testing to ensure purity, precision, safety, and reliability. With stable, outstanding quality and an inclusive positioning, TYILLO is exported to many countries and regions worldwide, becoming a trusted international health brand for millions of households and professional channels.

In the future, TYILLO will continue to deepen its global strategy, strengthen collaboration among its five independent production bases, and increase R&D investment in its four core research areas. It will continuously launch more precise, efficient, and safe health solutions. With full-chain independent control capabilities, TYILLO remains committed to the mission of “Tech for All, Health Without Borders”, bringing cutting-edge life sciences to people around the world and sharing a healthy future with the globe.